|
|
|
1-10 employees
View all
|
|
Biotechnology
|
|
235 Walnut Street, Framingham, MA 01702, US
|
|
Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch has received regulatory authorization to market AC5® Advanced Wound System and AC5® Topical Hemostat as medical devices in the United States and Europe, respectively. Arch's development stage product candidates include AC5-G™, AC5-V® and AC5® Surgical Hemostat, among others.1,2
1 AC5-G, AC5-V, and AC5 Surgical Hemostat are currently investigational devices limited by law to investigational use.
2 AC5, AC5-G, AC5-V and associated logos are trademarks and/or registered trademarks of Arch Therapeutics, Inc. and/or its subsidiaries.
|
Arch Therapeutics, Inc (OTCQB:ARTH) Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Arch Therapeutics, Inc (OTCQB:ARTH) email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Arch Therapeutics, Inc (OTCQB:ARTH) customer service number call here (617) 431-2317. To contact Arch Therapeutics, Inc (OTCQB:ARTH) customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.